Company Overview
Snapshot
Founded in June 2020 by Gideon Lapidoth and Dror Baran, Enzymit operates with 11–50 employees. The company has raised $17 million across 5 funding rounds from 8 investors. In September 2024, Enzymit secured Series A funding with participation from lead investors Khosla Ventures.
Business overview
Enzymit is a bioproduction platform company that develops cell-free enzymatic manufacturing technology to enhance the speed, simplicity, cost-effectiveness, and sustainability of bioproduction. The company's proprietary technology integrates complex computational design algorithms, deep-learning algorithms, and experimental tools to engineer novel enzymes. Enzymit primarily serves industries within Agriculture & Food Technologies, aiming to replace traditional chemical manufacturing with greener, more efficient enzymatic processes.
Strategic signal
In November 2025, Enzymit achieved the world's first scaled cell-free production of hyaluronic acid, a significant milestone that demonstrates the commercial viability and scalability of its biomanufacturing technology. This accomplishment, highlighted by multiple industry publications, signals a strong validation of Enzymit's platform and its potential to disrupt traditional chemical manufacturing processes across various sectors, including cosmetics and pharmaceuticals.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent product development for Enzymit?
- In November 2025, Enzymit achieved the world's first scaled cell-free production of hyaluronic acid, pioneering a novel biomanufacturing process in collaboration with Cosun.
- When did Enzymit secure its Series A funding round?
- Enzymit secured its Series A funding round in September 2024, with Khosla Ventures and Grove Ventures participating as lead investors.
- What was a key strategic partnership for Enzymit in 2023?
- In May 2023, Enzymit partnered with Aleph Farms to reduce production costs and shorten the time-to-market for cultivated meat, leveraging its bioproduction technology.
- What recognition did Enzymit receive from the World Economic Forum?
- In June 2024, Enzymit was recognized as one of the 2024 Technology Pioneers by the World Economic Forum, highlighting its innovative contributions to technology.
- What research did Enzymit publish in August 2023?
- In August 2023, new research demonstrated the application of Enzymit's deep learning technology for novel biocatalysis design, showcasing its potential to transform enzyme design and catalyze cell-free bioproduction across multiple industries.